COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

SARS-CoV-2 infection is required for COVID-19, but many signs and symptoms of COVID-19 differ from common acute viral diseases. Currently, there are no pre- or post-exposure prophylactic COVID-19 medical countermeasures. Clinical data suggest that famotidine may mitigate COVID-19 disease, but both m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Res Sq
Main Authors: Malone, Robert W., Tisdall, Philip, Fremont-Smith, Philip, Liu, Yongfeng, Huang, Xi-Ping, White, Kris M., Miorin, Lisa, Del Olmo, Elena Moreno, Alon, Assaf, Delaforge, Elise, Hennecker, Christopher D., Wang, Guanyu, Pottel, Joshua, Smith, Nora, Hall, Julie M., Shapiro, Gideon, Mittermaier, Anthony, Kruse, Andrew C., García-Sastre, Adolfo, Roth, Bryan L., Glasspool-Malone, Jill, Ricke, Darrell O.
Formato: Artigo
Idioma:Inglês
Publicado em: American Journal Experts 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336703/
https://ncbi.nlm.nih.gov/pubmed/32702719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-30934/v3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados